BackAgile Therapeutics Overview

Agile Therapeutics Cost of Revenue

Cost of Revenue analysis for AGRX.

Quarterly Cost of Revenue

$1.50M
35.15% YoY

As of Jun 30, 2024

Annual Cost of Revenue (TTM)

$7.84M
6.17% YoY

Trailing 12 months ending Jun 30, 2024

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)